| 000 | 016050000a22003490004500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223025704.0 | ||
| 008 | 081214s2008 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.08.M.Sc.2008.Ha.F | ||
| 100 | 0 | _aHala Massoud Mohammed Ali Elsadawi | |
| 245 | 1 | 0 |
_aFormulation and evaluation of anti - inflammatory drugs in topical dosage forms / _cHala Massoud Mohammed Ali Elsadawi ; Supervised Saadia Mohammed Tayel , Samia Hassan Shalby , Nagia Naguib Afifi |
| 246 | 1 | 5 | _aتصميم وتقييم الأدوية المضادة للالتهابات المستخدمة ظاهريا |
| 260 |
_aCairo : _bHala Massoud Mohammed Ali Elsadawi , _c2008 |
||
| 300 |
_a261P. : _bcharts ; _c25cm |
||
| 502 | _aThesis(M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aTenoxicam has been formulated into monolithic pathes using eudragits and blends of eudragits and PVP.The patches were tested for drug release and uniformity of grug content.The formulas that gave release to more than 50percent of the drug were chosen for further investigations | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAntiinflammatory | |
| 653 | 4 | _aPatches | |
| 653 | 4 | _aTenoxicam | |
| 700 | 0 |
_aNagia Naguib Afifi , _eSupervisor |
|
| 700 | 0 |
_aSaadia Mohammed Tayel , _eSupervisor |
|
| 700 | 0 |
_aSamia Hassan Shalby , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c18454 _d18454 |
||